sucujovide.wordpress.com
In 2003, , which had owned Eddie Bauer sincer 1988, filed for bankruptcy protection. And as part of the the company famous forits women’s wear cataloyg gave its creditors its stake in Eddie Bauer. So, in Eddie Bauer emerged as a stand-alone company for the firsg time in34 years. The company also emergedr witha $300 million senior securex term loan agreement with lenderds and the task of rebuildinyg a brand that had drifteed away from the company’s roots. Unded Spiegel, grew rapidly, from 58 to 399 retaill stores and from three to102 outlets. The company also addec internet sales.
But it also was a time when the Eddid Bauer brand lost its as the company shifted from its heritage as an outdooer outfitter to a seller of casual clotheas targeted primarilyat women. Company executives have said the debt termss from the Spiegel bankruptcy case have continued to hampe r efforts to turn things around atEddie Bauer. Despites efforts to recapture some of theold magic, Eddis Bauer has not been able to establish a sustainabler run of profitable quarters. The company racked up nine consecutivwe quartersof loses, and has seen losses of nearl a half-billion dollars in the past three years.
The struggled became a financial crisis as the recessiob has worsened and consumers haveslowed spending.
Monday, December 10, 2012
Saturday, December 8, 2012
Proposed Tennessee bill would tax visiting NBA, NHL players - Phoenix Business Journal:
goldenayreyg1666.blogspot.com
Under House Bill 0019, Tennessee would tax athletes and entertainerds performing in the state who make morethan $50,0090 a year. The bill would increaswe state revenue by morethan $1.1 milliob and the funds would be used for juvenilr court-related programs. The tax would covedr opponents of the and for up to three gamesda year. However, opponents of the wouldr be exempt. Greg Campbell, president of business operations for theMemphies Grizzlies, said other states have similar taxes for professional teams. “We are awarer of the state's intention to pass a bill that wouldc impose a privilege tax on professional basketball players in the state of Campbell said.
“We will be keeping a closer eye on this as it continues to move througb the approval process and trustthat Gov. (Phil) Bredesem and his fellow lawmakers will continu to do what is best for Tennessee and professional basketball in the At least 15 other statee have a similar taxincludingf Illinois, Wisconsin, Minnesota, Colorado, Arizona, New Jersey, Nort Carolina, Louisiana, Oklahoma, Ohio, Massachusetts, Indiana and Pennsylvania. Michigan has a reciprocal law in place that charges players that play for teamsz with the tax but not players that play in statesewithout it.
Under House Bill 0019, Tennessee would tax athletes and entertainerds performing in the state who make morethan $50,0090 a year. The bill would increaswe state revenue by morethan $1.1 milliob and the funds would be used for juvenilr court-related programs. The tax would covedr opponents of the and for up to three gamesda year. However, opponents of the wouldr be exempt. Greg Campbell, president of business operations for theMemphies Grizzlies, said other states have similar taxes for professional teams. “We are awarer of the state's intention to pass a bill that wouldc impose a privilege tax on professional basketball players in the state of Campbell said.
“We will be keeping a closer eye on this as it continues to move througb the approval process and trustthat Gov. (Phil) Bredesem and his fellow lawmakers will continu to do what is best for Tennessee and professional basketball in the At least 15 other statee have a similar taxincludingf Illinois, Wisconsin, Minnesota, Colorado, Arizona, New Jersey, Nort Carolina, Louisiana, Oklahoma, Ohio, Massachusetts, Indiana and Pennsylvania. Michigan has a reciprocal law in place that charges players that play for teamsz with the tax but not players that play in statesewithout it.
Friday, December 7, 2012
Japan drug giant Takeda bets big on Bay Area facility - Puget Sound Business Journal (Seattle):
adamovaichive.blogspot.com
A company with worldwide revenueof $14.7 billion, Takeda openedr its unit a year ago to be the company’zs primary source for research and developmeny in antibodies. The 60,000-square-foot Souty San Francisco facilityemploys 40, but the unit is expectede to grow to 100 employeesd by the end of 2009. Although this is not Takeda’e first venture in the United States, it is the firstg R&D facility that the company built from the grounx up outsideof Japan. Takeds has facilities in San Diego, Bostomn and Chicago — all from subsidiaries boughr by Takeda. (Most Takeda added to its U.S.
holdings by closing the largestf deal ever by a Japanese drug firm when itacquirer Cambridge, Mass., biotech to the tune of $8.8 billion in May.) Mary president and CEO of Takeda San Francisco, said that Japan’s largest drug company, wanted a “stronger globakl presence” in antibody research and selectecd San Francisco not only because it is the “birthplac of biotechnology,” but also for its status as a centrak area for antibody research. It’s not surprising that Takedw is pumping money into Not only do antibodies hold a lot of promise on treatingv diseaseslike cancer, but the technologies stand to be a huge revenuer maker.
Five of the top-selling cancer drugs, includingh ’s popular chemotherapy drug are madefrom antibodies. Monoclonal antibodies target cancercells specifically. These targeted therapies are not only thought to be more successfu in treating cancer andimmune diseases, but are also knownn to cause fewer side effects to patients. Accordingb to Haak-Frendscho, the benefits of establishingga R&D facility in the Bay Area includse drawing from a talent pool “withy the biggest concentration of experienced professionals in antibodyy therapeutics” and being where the competition is located.
headquartered down the street in SouthSan Francisco, and are just two of the biotechss that have R&D facilities devoted to developing antibodhy therapies in the Bay Area. Takeds is in such a hurry to develoop the antibody technologies that it iscontractinbg R&D work to local biotech while its laboratories are beinhg built. In 2006, Takeda collaborated with Ltd., a Berkelet company whose expertise in developing antibodies made it an idea l candidate forthe partnership. According to Xoma was expected to make closeto $100 millioh from the deal. “Takeda has put a stakew in the ground in theantibody field,” said Pat vice president of collaborations businessd for Xoma.
“Takeda identifie d an area in the world where thered is a high concentration of people who understandantibodh technologies. I think, in general, big pharma is lookinhg to settle in an area where they can leverage the expertiswe of other companiesand talent.” Matt Gardner, CEO of a biosciences trade association, said that Takeda is one of many multinational research and drug companies that are lookingg to San Francisco to harnesz antibody technology. “Its a powerful reminderr that it’s the human-capital elementr that makes the Bay Area competitive in theantibodyt industry,” Gardner said.
A company with worldwide revenueof $14.7 billion, Takeda openedr its unit a year ago to be the company’zs primary source for research and developmeny in antibodies. The 60,000-square-foot Souty San Francisco facilityemploys 40, but the unit is expectede to grow to 100 employeesd by the end of 2009. Although this is not Takeda’e first venture in the United States, it is the firstg R&D facility that the company built from the grounx up outsideof Japan. Takeds has facilities in San Diego, Bostomn and Chicago — all from subsidiaries boughr by Takeda. (Most Takeda added to its U.S.
holdings by closing the largestf deal ever by a Japanese drug firm when itacquirer Cambridge, Mass., biotech to the tune of $8.8 billion in May.) Mary president and CEO of Takeda San Francisco, said that Japan’s largest drug company, wanted a “stronger globakl presence” in antibody research and selectecd San Francisco not only because it is the “birthplac of biotechnology,” but also for its status as a centrak area for antibody research. It’s not surprising that Takedw is pumping money into Not only do antibodies hold a lot of promise on treatingv diseaseslike cancer, but the technologies stand to be a huge revenuer maker.
Five of the top-selling cancer drugs, includingh ’s popular chemotherapy drug are madefrom antibodies. Monoclonal antibodies target cancercells specifically. These targeted therapies are not only thought to be more successfu in treating cancer andimmune diseases, but are also knownn to cause fewer side effects to patients. Accordingb to Haak-Frendscho, the benefits of establishingga R&D facility in the Bay Area includse drawing from a talent pool “withy the biggest concentration of experienced professionals in antibodyy therapeutics” and being where the competition is located.
headquartered down the street in SouthSan Francisco, and are just two of the biotechss that have R&D facilities devoted to developing antibodhy therapies in the Bay Area. Takeds is in such a hurry to develoop the antibody technologies that it iscontractinbg R&D work to local biotech while its laboratories are beinhg built. In 2006, Takeda collaborated with Ltd., a Berkelet company whose expertise in developing antibodies made it an idea l candidate forthe partnership. According to Xoma was expected to make closeto $100 millioh from the deal. “Takeda has put a stakew in the ground in theantibody field,” said Pat vice president of collaborations businessd for Xoma.
“Takeda identifie d an area in the world where thered is a high concentration of people who understandantibodh technologies. I think, in general, big pharma is lookinhg to settle in an area where they can leverage the expertiswe of other companiesand talent.” Matt Gardner, CEO of a biosciences trade association, said that Takeda is one of many multinational research and drug companies that are lookingg to San Francisco to harnesz antibody technology. “Its a powerful reminderr that it’s the human-capital elementr that makes the Bay Area competitive in theantibodyt industry,” Gardner said.
Thursday, December 6, 2012
'Isaac Newton vs. Rube Goldberg:' 2D House's Machine Will Make You Question ... - Huffington Post
ogarawo.wordpress.com
'Isaac Newton vs. Rube Goldberg:' 2D House's Machine Will Make You Question ... Huffington Post Rube Goldberg -- takes the classic contraption to new extremes. Toronto-based commercial cinematography company 2D House added a twist to the concept, ch » |
Tuesday, December 4, 2012
S&P lowers outlook for HEI, HECO - The Business Journal of Milwaukee:
ogarawo.wordpress.com
Standard & Poor’s said Hawaii is “exhibitinh decidedly recessionary trends,” and that its dependenc on tourism to drive the local economy could mean the state will be more severelt affected bythe recession. “The negative outlook assigneed to HEI reflects the potentia for consolidated credit metrics to fall below our benchmarks over our outlool horizon dueto Hawaii’s weakenin economy, which is expected to lower electric sales by 4 percent or more and put upward pressure on borrowingf requirements,” S&P said. , a subsidiargy of HEI, is rated on a standalon basis and is not affected by the lowered Shares of Hawaiian Electric stock weredown 1.
6 percenr to $16.95.
Standard & Poor’s said Hawaii is “exhibitinh decidedly recessionary trends,” and that its dependenc on tourism to drive the local economy could mean the state will be more severelt affected bythe recession. “The negative outlook assigneed to HEI reflects the potentia for consolidated credit metrics to fall below our benchmarks over our outlool horizon dueto Hawaii’s weakenin economy, which is expected to lower electric sales by 4 percent or more and put upward pressure on borrowingf requirements,” S&P said. , a subsidiargy of HEI, is rated on a standalon basis and is not affected by the lowered Shares of Hawaiian Electric stock weredown 1.
6 percenr to $16.95.
Monday, December 3, 2012
Dean Foods to relocate corporate office - Dayton Business Journal:
xysecurakihir.blogspot.com
Dallas-based Dean (NYSE: DF) will relocate from its curren location at 2515McKinney Ave. into 240,000 squares feet of space inside The move is expectexd to take place in the firstf quarterof 2010. "We are pleased to be able to relocat our offices within Dallascity limits. Many factors worked in our including the realestate market, space availability and otherd economic elements," said Gregg Engles, chairman of the boarfd and chief executive officer of Dean Foods. "Thde City of Dallas is our home, and we are please to remain here and continu our many civic andcommunity partnerships.
" Dean said in a statemen t it is moving because the company has outgrown its currenty workspace, and new space is needed to address the company’d changing needs. The lease will take occupancy at Cityplac to about 80 percent from abou 60percent now, said Saran Payne, vice president at Stream Realty Partners, whichn handles leasing in the building. Employees will begih moving in December and the move will be phased inthroughh March, Payne said.
"This was a huge win for the City of Dallaes to keep them inthe city, becausw they looked all over," Payne She said Dean Fooda considered existing space and build-to-suites in the Legacy/Frisco area, as well as othee buildings downtown. Brokers familiar with the search said Dean Foods considered Fountainb Place and Bank of America Plazaw among other downtown buildings with significant squarefootagd available. The asking lease rate for space in Cityplace is $24 per square foot, plus electricity. Dean Fooda will occupy floors 34 through 40 inthe 1.2-million-square-foot building. Dean Foods occupiesd about 150,000 square feet at its currentf location.
Dallas-based Dean (NYSE: DF) will relocate from its curren location at 2515McKinney Ave. into 240,000 squares feet of space inside The move is expectexd to take place in the firstf quarterof 2010. "We are pleased to be able to relocat our offices within Dallascity limits. Many factors worked in our including the realestate market, space availability and otherd economic elements," said Gregg Engles, chairman of the boarfd and chief executive officer of Dean Foods. "Thde City of Dallas is our home, and we are please to remain here and continu our many civic andcommunity partnerships.
" Dean said in a statemen t it is moving because the company has outgrown its currenty workspace, and new space is needed to address the company’d changing needs. The lease will take occupancy at Cityplac to about 80 percent from abou 60percent now, said Saran Payne, vice president at Stream Realty Partners, whichn handles leasing in the building. Employees will begih moving in December and the move will be phased inthroughh March, Payne said.
"This was a huge win for the City of Dallaes to keep them inthe city, becausw they looked all over," Payne She said Dean Fooda considered existing space and build-to-suites in the Legacy/Frisco area, as well as othee buildings downtown. Brokers familiar with the search said Dean Foods considered Fountainb Place and Bank of America Plazaw among other downtown buildings with significant squarefootagd available. The asking lease rate for space in Cityplace is $24 per square foot, plus electricity. Dean Fooda will occupy floors 34 through 40 inthe 1.2-million-square-foot building. Dean Foods occupiesd about 150,000 square feet at its currentf location.
Sunday, December 2, 2012
Cherished guitar stolen before sell out Pyramid gig - This Is Cheshire
sucujovide.wordpress.com
Cherished guitar stolen before sell out Pyramid gig This Is Cheshire A MUSICIAN has been left heartbroken after his cherished guitar was stolen a week before a sold out gig at the Pyramid. Pete Price, aged 53, hit out at the thieves after they entered his home on Thelwall New Road in Latchford to take the precious ... |
Subscribe to:
Posts (Atom)